Alzheimer's Disease Research

Since 1985, the Alzheimer's Disease Research (ADR) program has awarded nearly $170 million to support promising research in fields ranging from molecular biology to genetics to epidemiology. ADR is currently supporting 167 outstanding biomedical researcher projects.

Dr. David Irwin looking into a microscope,

Request for Proposal

Highlights

A Precivity scientist working in the lab.

BrightFocus an Early Supporter of “Game Changing” Alzheimer’s Disease Blood Test

An illustration of DNA molecules.

New Genes and Variants Discovered to Contribute to Alzheimer’s Risk

Fats accumulating in brain immune cells surrounded by amyloid plaques.

New Evidence on How TREM2 Gene and Mutations Impact Alzheimer’s

An illustration of neurons.

Alzheimer's Fast Track 2022

Logos of Astrocyte, MTEC, and BrightFocus Foundation.

Astrocyte Pharmaceuticals Awarded Major Grant to Further Develop Promising Treatment for Brain Injury

Dr. Patrick Kehoe speaking at the podium.

BrightFocus Alzheimer’s Researcher Offers Insights into COVID-19